CD19 Polyclonal Antibody

Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. CD19 encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.

The CD19 Polyclonal Antibody is a highly specific and sensitive immunological reagent designed for the detection and quantification of CD19 protein expression in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the extracellular domain of human CD19 protein. The resulting polyclonal antibody exhibits high affinity and specificity towards CD19 protein, making it an ideal tool for a wide range of research applications.

The CD19 Polyclonal Antibody is suitable for use in various immunoassays, including Western blotting, immunohistochemistry, and flow cytometry. It has been validated for use in human, mouse, and rat samples, and has been shown to detect CD19 protein expression in a variety of tissues and cell types. This antibody is supplied as a liquid formulation in phosphate-buffered saline (PBS) with 0.02% sodium azide as a preservative.

The CD19 Polyclonal Antibody is a valuable tool for researchers studying the role of CD19 in various biological processes, including B cell development, activation, and differentiation. It can also be used to investigate the expression of CD19 in various diseases, such as B cell lymphomas and leukemias. With its high sensitivity and specificity, this antibody is an essential reagent for any laboratory conducting research in the field of immunology.